We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
(+12%)
Cap. Flow
+$857M
Cap. Flow
% of AUM
6.4%
Top 10 Holdings %
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$175M |
| 2 |
Lowe's Companies
LOW
|
+$167M |
| 3 |
AutoZone
AZO
|
+$127M |
| 4 |
Northern Trust
NTRS
|
+$127M |
| 5 |
Merck
MRK
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$133M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$126M |
| 3 |
KeyCorp
KEY
|
+$113M |
| 4 |
Walmart Inc
WMT
|
+$110M |
| 5 |
OA
Orbital ATK, Inc.
OA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.72% |
| 2 | Industrials | 14.06% |
| 3 | Consumer Discretionary | 12.07% |
| 4 | Healthcare | 11.22% |
| 5 | Financials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Insmed
INSM
$28.9B
| $9.21M | 0.07% |
+295,098
| New | +$5.62M |
|
|
ZEN
252
DELISTED
ZENDESK INC
ZEN
| $9.02M | 0.07% |
+309,740
| New | +$8.69M |
|
|
NXTM
253
DELISTED
NxStage Medical Inc.
NXTM
| $8.82M | 0.07% |
+319,666
| New | +$8.53M |
|
|
ADSW
254
DELISTED
Advanced Disposal Services Inc
ADSW
| $8.82M | 0.07% |
350,000
-825,000
| -70% | -$19.5M |
|
|
ITCI
255
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $8.66M | 0.06% |
+548,955
| New | +$8.06M |
|
256
Burlington
BURL
$23.4B
| $8.4M | 0.06% |
+87,986
| New | +$7.72M |
|
|
SCTL
257
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $8.14M | 0.06% |
1,010,634
+33,226
| +3% | +$228K |
|
|
SNAK
258
DELISTED
Inventure Foods, Inc.
SNAK
| $8.06M | 0.06% |
1,718,620
+426,696
| +33% | +$1.62M |
|
|
SCWX
259
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $8.03M | 0.06% |
650,000
-28,438
| -4% | -$311K |
|
260
J. Jill
JILL
$280M
| $7.97M | 0.06% |
174,410
+52,852
| +43% | +$2.5M |
|
261
MBIA
MBI
$269M
| $7.94M | 0.06% |
+912,469
| New | +$9.16M |
|
262
Rapid7
RPD
$694M
| $7.9M | 0.06% |
+448,641
| New | +$7.45M |
|
263
Signet Jewelers
SIG
$3.65B
| $7.86M | 0.06% |
+118,159
| New | +$7.27M |
|
|
NAV
264
DELISTED
Navistar International
NAV
| $7.63M | 0.06% |
173,073
-226,057
| -57% | -$7.5M |
|
|
EACQ
265
CALL
DELISTED
Easterly Acquisition Corp
EACQ
| $7.62M | 0.06% |
761,707
| – | – |
|
|
FG
266
CALL
DELISTED
FGL Holdings Ordinary Shares
FG
| $7.56M | 0.06% |
675,000
| – | – |
|
267
Coherus Oncology
CHRS
$194M
| $7.47M | 0.06% |
559,581
-26,446
| -5% | -$350K |
|
268
JELD-WEN Holding
JELD
$154M
| $7.1M | 0.05% |
200,000
-131,241
| -40% | -$4.15M |
|
|
BPMC
269
DELISTED
Blueprint Medicines
BPMC
| $6.97M | 0.05% |
+100,000
| New | +$5.34M |
|
|
SAGE
270
DELISTED
Sage Therapeutics
SAGE
| $6.9M | 0.05% |
110,797
+26,348
| +31% | +$2.07M |
|
|
SGYP
271
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $6.83M | 0.05% |
2,355,681
+696,911
| +42% | +$2.38M |
|
272
lululemon athletica
LULU
$14.2B
| $6.67M | 0.05% |
+107,207
| New | +$6.46M |
|
273
CALL
Verra Mobility
VRRM
$778M
| $6.65M | 0.05% |
666,668
+2
| +0% | +$20 |
|
|
AYX
274
DELISTED
Alteryx Inc
AYX
| $6.62M | 0.05% |
+325,000
| New | +$6.89M |
|
|
DSKE
275
DELISTED
Daseke, Inc. Common Stock
DSKE
| $6.53M | 0.05% |
+500,000
| New | +$6.23M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q3 2017 Portfolio in Review
As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.
- Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
- Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
- Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
- Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
- Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
- Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.
Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.